930286-87-6 Usage
Uses
Used in Pharmaceutical Development:
1H-Pyrazol-3-aMine, 4-broMo-N,N,1-tris[(4-Methoxyphenyl)Methyl]is used as a key component in the development of pharmaceutical drugs due to its unique structure and properties. The presence of the bromine atom and tris(4-methoxyphenyl)methyl groups allows for the compound to be tailored for specific therapeutic applications, making it a valuable asset in the creation of new medications.
Used in Organic Synthesis:
In the field of organic synthesis, 1H-Pyrazol-3-aMine, 4-broMo-N,N,1-tris[(4-Methoxyphenyl)Methyl]serves as a versatile reagent. Its distinctive structure enables it to participate in a variety of chemical reactions, facilitating the synthesis of complex organic molecules. This makes it an essential tool for researchers and chemists working on the development of new compounds and materials.
Used in Research and Industrial Applications:
1H-Pyrazol-3-aMine, 4-broMo-N,N,1-tris[(4-Methoxyphenyl)Methyl]is also utilized in research and industrial applications due to the specific properties imparted by its tris(4-methoxyphenyl)methyl groups. These properties can be harnessed to improve the performance of various products and processes, making the compound a valuable resource across multiple industries.
Check Digit Verification of cas no
The CAS Registry Mumber 930286-87-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,0,2,8 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 930286-87:
(8*9)+(7*3)+(6*0)+(5*2)+(4*8)+(3*6)+(2*8)+(1*7)=176
176 % 10 = 6
So 930286-87-6 is a valid CAS Registry Number.
930286-87-6Relevant articles and documents
NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
-
Paragraph 0087; 0088, (2016/04/19)
In its many embodiments, the present invention provides a class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases (CDKs), methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds
A convergent preparation of the CHK1 inhibitor MK-8776 (SCH 900776)
Labroli, Marc A.,Dwyer, Michael P.,Poker, Cory,Keertikar, Kerry M.,Rossman, Randall,Guzi, Timothy J.
, p. 2601 - 2603 (2016/06/01)
This Letter describes the development of a convergent, efficient route to the CHK1 inhibitor MK-8776. This synthetic approach relies upon the cyclization of a bispyrazole adduct 10 with a optically pure β-keto nitrile 9 to construct the pyrazolo[1,5-a]pyrimidine scaffold in a single step.
Methods for inhibiting protein kinases
-
Page/Page column 132, (2010/11/26)
The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim kinases, and tyrosine kinase using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevent